-
Real Time Chart
-
Stock Profile
-
Stock Fundamentals
Financials As Reported
-
accession Number
0001558370-23-009134
-
accounts Payable Current
31,572,000
-
accumulated Depreciation Depletion And Amortization Property Plant And Equipment
19,374,000
-
accumulated Other Comprehensive Income Loss Net Of Tax
--126,000
-
amendment Flag
false
-
assets
824,767,000
-
assets Current
637,781,000
-
cash And Cash Equivalents At Carrying Value
543,484,000
-
cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
549,914,000
-
cik
1,425,205
-
city Area Code
650
-
common Stock Par Or Stated Value Per Share
4.1666E-05
-
common Stock Shares Authorized
300,000,000
-
common Stock Shares Issued
224,358,979
-
common Stock Shares Outstanding
224,358,979
-
comprehensive Income Net Of Tax
--106,594,000
-
current Fiscal Year End Date
--12-31
-
date Filed
2023-05-10
-
depreciation
2,800,000
-
depreciation Depletion And Amortization
2,764,000
-
document Fiscal Period Focus
Q1
-
document Fiscal Year Focus
2,023
-
document Period End Date
2023-03-31
-
document Transition Report
false
-
document Type
10-Q
-
earnings Per Share Basic
-0.5
-
earnings Per Share Diluted
-0.5
-
entity Address Address Line 1
825 Industrial Road, Suite 400
-
entity Address City Or Town
San Carlos
-
entity Address Postal Zip Code
94,070
-
entity Address State Or Province
CA
-
entity Central Index Key
1,425,205
-
entity Current Reporting Status
Yes
-
entity Emerging Growth Company
false
-
entity File Number
001-36860
-
entity Filer Category
Large Accelerated Filer
-
entity Incorporation State Country Code
DE
-
entity Interactive Data Current
Yes
-
entity Name
IOVANCE BIOTHERAPEUTICS, INC.
-
entity Registrant Name
IOVANCE BIOTHERAPEUTICS, INC.
-
entity Shell Company
false
-
entity Small Business
false
-
entity Tax Identification Number
75-3254381
-
increase Decrease In Accounts Payable
3,025,000
-
irs Number
753,254,381
-
lessee Operating Lease Liability Payments Due
132,918,000
-
lessee Operating Lease Liability Payments Due Next Twelve Months
10,605,000
-
lessee Operating Lease Liability Payments Due Year Four
8,186,000
-
lessee Operating Lease Liability Payments Due Year Three
7,989,000
-
lessee Operating Lease Liability Payments Due Year Two
8,240,000
-
lessee Operating Lease Liability Undiscounted Excess Amount
50,692,000
-
liabilities
157,886,000
-
liabilities And Stockholders Equity
824,767,000
-
liabilities Current
87,274,000
-
liabilities Noncurrent
70,612,000
-
local Phone Number
260-7120
-
net Cash Provided By Used In Financing Activities
258,172,000
-
net Cash Provided By Used In Investing Activities
153,396,000
-
net Cash Provided By Used In Operating Activities
--99,800,000
-
net Income Loss
--107,400,000
-
operating Expenses
110,856,000
-
operating Income Loss
--110,856,000
-
operating Lease Cost
4,524,000
-
operating Lease Liability
82,226,000
-
operating Lease Liability Current
12,614,000
-
operating Lease Liability Noncurrent
69,612,000
-
operating Lease Payments
4,161,000
-
operating Lease Right Of Use Asset
70,431,000
-
other Assets Noncurrent
202,000
-
other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
776,000
-
payments Related To Tax Withholding For Share Based Compensation
1,929,000
-
payments To Acquire Available For Sale Securities Debt
5,323,000
-
payments To Acquire Property Plant And Equipment
5,664,000
-
period End
1,680,220,800,000
-
period Start
1,672,531,200,000
-
property Plant And Equipment Gross
129,297,000
-
property Plant And Equipment Net
109,923,000
-
report Link
https://www.sec.gov/Archives/edgar/data/1425205/000155837023009134/iova-20230331x10q_htm.xml
-
research And Development Expense
82,734,000
-
retained Earnings Accumulated Deficit
--1,675,708,000
-
share Based Compensation
15,665,000
-
stockholders Equity
666,881,000
-
trading Symbol
IOVA
-
update
1970-01-01
-
variable Lease Cost
1,694,000
-
weighted Average Number Of Diluted Shares Outstanding
213,694,000
-
weighted Average Number Of Shares Outstanding Basic
213,694,000
-
id
REPORTED_FINANCIALS
-
key
IOVA
-
subkey
10-Q
-
date
2023-05-10
-
updated
2023-05-11
-
Symbol Info
-
Symbol Over View
-
Technical Analysis
IOVA stock fundamentals - financials as reported